PharmaBlock Sciences (Nanjing)

SHE-300725
Shenzhen Stock Exchange
Healthcare Drug Manufacturers - Specialty & Generic
Global Rank
#8291
Country Rank
#2080
Market Cap
1.3 B
Price
6.54
Change (%)
4.24%
Volume
20.84 M

PharmaBlock Sciences (Nanjing)'s latest marketcap:

1.3 B

As of 08/02/2025, PharmaBlock Sciences (Nanjing)'s market capitalization has reached $1.3 B. According to our data, PharmaBlock Sciences (Nanjing) is the 8291th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 1.3 B
Revenue (ttm) 244.9 M
Net Income (ttm) 28.54 M
Shares Out 198.89 M
EPS (ttm) 0.14
Forward PE 43.35
Ex-Dividend Date 05/30/2025
Earnings Date 08/08/2025
Market Cap Chart
Data Updated: 08/02/2025

PharmaBlock Sciences (Nanjing)'s yearly market capitalization.

PharmaBlock Sciences (Nanjing) has seen its market value grow from ¥8.38 B to ¥9.4 B since 2017, representing a total increase of 12.12% and an annual compound growth rate (CAGR) of 1.52%.
Date Market Cap(¥) Market Cap(USD) Change (%) Global Rank
08/02/2025 ¥9.4 B $1.3 B 46.66% 8291
12/31/2024 ¥6.68 B $914.92 M -14.8% 9277
12/29/2023 ¥7.84 B $1.1 B -51.22% 8127
12/30/2022 ¥16.07 B $2.33 B -43.39% 4849
12/31/2021 ¥28.39 B $4.47 B 41.66% 3521
12/31/2020 ¥20.04 B $3.07 B 102.57% 4073
12/31/2019 ¥9.89 B $1.42 B 67.08% 5581
12/28/2018 ¥5.92 B $860.96 M -29.36% 6677
12/29/2017 ¥8.38 B $1.29 B 6068

Company Profile

About PharmaBlock Sciences (Nanjing), Inc.

PharmaBlock Sciences (Nanjing), Inc. is a leading provider of chemistry products and services, supporting the entire pharmaceutical lifecycle—from research and development to commercial production.

Core Business Offerings

  • Building Blocks Collection: Comprehensive supply chain from discovery to commercial stages.
  • Drug Discovery Solutions: Building blocks-driven libraries to accelerate early-stage research.
  • Development & Manufacturing: Expertise in RSMs, intermediates, APIs, and finished drug products for development and commercialization.

Company Background

Founded in 2006, PharmaBlock Sciences is headquartered in Nanjing, China, and serves the global pharmaceutical industry with innovative chemistry solutions.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.